Jacob M. Chacko's Insider Trades & SAST Disclosures
Jacob M. Chacko's most recent trade in ORIC Pharmaceuticals Inc was a trade of 600,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jacob M. Chacko.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 100,000 | 100,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 67,000 | 803,308 | - | 0 | Common Stock | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 28,333 | 56,667 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 15 Dec 2024 | 24,660 | 778,648 | - | 8.3 | 204,214 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 22,000 | 22,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 16,667 | 0 | - | - | Restricted Stock Unit | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 06 Mar 2024 | 40,000 | 728,544 | - | 16.2 | 648,380 | Common Stock |
| ORIC Pharmaceuticals Inc | M. Chacko Jacob | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.29 per share. | 06 Feb 2024 | 26,042 | 768,544 | - | 12.3 | 320,186 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 06 Feb 2024 | 13,958 | 794,586 | - | 12.1 | 169,160 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 510,000 | 510,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | M. Jacob Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 85,000 | 85,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Chacko Jacob M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 38,667 | 823,083 | - | 0 | Common Stock | |
| ORIC Pharmaceuticals Inc | M. Jacob Chacko | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 22,000 | 44,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob Chacko M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 16,667 | 16,667 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 15 Dec 2023 | 14,539 | 808,544 | - | 8.6 | 124,813 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 10 Jul 2023 | 10,508 | 785,808 | - | 8.0 | 84,212 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 10 Jul 2023 | 5,156 | 780,652 | - | 8.0 | 41,287 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 05 Jul 2023 | 4,336 | 796,316 | - | 8.0 | 34,711 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.03 per share. | 26 Jun 2023 | 20,000 | 800,652 | - | 8.0 | 160,562 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 21 Apr 2023 | 5,000 | 0 | - | 20.1 | 100,270 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 5,000 | 32,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 21 Apr 2023 | 5,000 | 5,000 | - | 9.4 | 47,050 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 66,000 | 66,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 437,500 | 0 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 437,500 | 437,500 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 300,000 | 0 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 280,000 | 280,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 280,000 | 0 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 11 May 2022 | 304,574 | 657,226 | - | 2.9 | 883,569 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 11 May 2022 | 76,072 | 802,652 | - | 2.8 | 214,561 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 11 May 2022 | 69,354 | 726,580 | - | 2.7 | 190,467 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 23 Mar 2022 | 257,127 | 259,779 | - | 5.0 | 1,280,878 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.54 per share. | 23 Mar 2022 | 50,000 | 352,652 | - | 4.5 | 227,170 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 23 Mar 2022 | 42,873 | 302,652 | - | 5.0 | 215,660 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 14 Sep 2021 | 4,420 | 6,388 | - | 25.0 | 110,706 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 14 Sep 2021 | 3,736 | 2,652 | - | 25.1 | 93,629 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 10 Sep 2021 | 2,942 | 13,609 | - | 25.1 | 73,783 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 10 Sep 2021 | 2,801 | 10,808 | - | 25.0 | 70,089 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 07 Sep 2021 | 5,981 | 16,751 | - | 25.1 | 150,173 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 07 Sep 2021 | 200 | 16,551 | - | 25.0 | 5,007 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 20 May 2021 | 4,790 | 23,144 | - | 25.2 | 120,688 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 20 May 2021 | 2,468 | 27,934 | - | 25.1 | 61,864 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 20 May 2021 | 12 | 23,132 | - | 25 | 300 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.36 per share. | 14 May 2021 | 13,896 | 44,284 | - | 25.4 | 352,465 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.37 per share. | 14 May 2021 | 11,132 | 30,602 | - | 25.4 | 282,428 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 14 May 2021 | 2,550 | 41,734 | - | 25.1 | 63,884 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.03 per share. | 14 May 2021 | 200 | 30,402 | - | 26.0 | 5,206 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 11 May 2021 | 1,090 | 59,310 | - | 25.2 | 27,490 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 11 May 2021 | 730 | 58,180 | - | 25.0 | 18,281 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 11 May 2021 | 400 | 58,910 | - | 25.0 | 10,010 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.09 per share. | 01 Apr 2021 | 800 | 61,700 | - | 25.1 | 20,070 | Common Stock |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 280,000 | 280,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | 28 Apr 2020 | 62,500 | 0 | - | - | Series C Preferred Stock | ||
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | 28 Apr 2020 | 62,500 | 62,500 | - | - | Common Stock | ||
| ORIC Pharmaceuticals Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 437,500 | 437,500 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges